Spero Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A.
CEOEsther Rajavelu
CEOEsther Rajavelu
Employees32
Employees32
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees32
Employees32
SPRO Key Statistics
Market cap138.38M
Market cap138.38M
Price-Earnings ratio-1.94
Price-Earnings ratio-1.94
Dividend yield—
Dividend yield—
Average volume1.04M
Average volume1.04M
High today$2.52
High today$2.52
Low today$2.45
Low today$2.45
Open price$2.49
Open price$2.49
Volume867.35K
Volume867.35K
52 Week high$3.22
52 Week high$3.22
52 Week low$0.5052
52 Week low$0.5052
SPRO News
Simply Wall St 16h
Insufficient Growth At Spero Therapeutics, Inc. Hampers Share PriceWith a price-to-sales (or "P/S") ratio of 3.1x Spero Therapeutics, Inc. ( ) may be sending very bullish signals at the moment, given that almost half of all the...
People also own
Based on the portfolios of people who own SPRO. This list is generated using Robinhood data, and it’s not a recommendation.